VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > Platform for Fund Managers to Profit From Short Sellers

<< Previous

Bullboard Posts

Next >>

Comment by GarlicToaston Apr 28, 2021 9:10am

126 Views

Post# 33081239

RE:Platform for Fund Managers to Profit From Short Sellers

I really hate these short selling cockroaches, stealing people money, spreading lies and misinformation to destroy companies struggling to raise capital.
I hope the Wallstreetbets movement escalate and crush these maggots.

<< Previous

Bullboard Posts

Next >>

Visionstate set to leverage success in the U.S. market